| Form type | Sec Links | Description | Filing date | Reporting date |
|---|---|---|---|---|
| SC 13D/A | Report | GROWTH EQUITY OPPORTUNITIES FUND IV (ADDEX THERAPEUTICS) - SCHEDULE 13D/A(#7E) | Aug 14, 2024 | |
| SC 13D/A | Report | GROWTH EQUITY OPPORTUNITIES FUND IV (ADDEX THERAPEUTICS) - SCHEDULE 13D/A(#6) | Aug 5, 2024 | |
| SC 13D/A | Report | GROWTH EQUITY OPPORTUNITIES FUND IV (ADDEX THERAPEUTICS) - SCHEDULE 13D/A(#5) | Dec 8, 2023 | |
| SC 13D/A | Report | SC 13D/A | Nov 29, 2023 | |
| SC 13D/A | Report | GROWTH EQUITY OPPORTUNITIES FUND IV (ADDEX THERAPEUTICS) - SCHEDULE 13D/A(#4) | Apr 10, 2023 | |
| SC 13D/A | Report | SC 13D/A | Apr 5, 2023 | |
| SC 13D/A | Report | SC 13D/A | Mar 31, 2023 | |
| SC 13D/A | Report | GROWTH EQUITY OPPORTUNITIES FUND IV (ADDEX THERAPEUTICS) - SCHEDULE 13D/A3 | Nov 28, 2022 | |
| SC 13D/A | Report | SC 13D/A | Nov 23, 2022 | |
| SC 13D/A | Report | SC 13D/A | Nov 9, 2022 | |
| SC 13D/A | Report | GROWTH EQUITY OPPORTUNITIES FUND IV (ADDEX THERAPEUTICS) - SCHEDULE 13D/A2 | Aug 23, 2022 | |
| SC 13D/A | Report | SC 13D/A | Aug 5, 2022 | |
| SC 13D/A | Report | GROWTH EQUITY OPPORTUNITIES FUND IV (ADDEX THERAPEUTICS) - SCHEDULE 13DA1 | Jan 10, 2022 | |
| SC 13D/A | Report | SC 13D/A | Sep 8, 2021 | |
| SC 13D | Report | GROWTH EQUITY OPPORTUNITIES FUND IV (ADDEX THERAPEUTICS) - SCHEDULE 13D | Jan 22, 2021 | |
| SC 13D | Report | SC 13D | Nov 3, 2020 |